Neostigmine methylsulfate
NDC 70121-1478, Neostigmine methylsulfate, injection, from Amneal Pharmaceuticals LLC.
- Product NDC
- 70121-1478
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210051
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70121-1478 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEOSTIGMINE METHYLSULFATE.5 mg/mL
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70121-1478-7 | 70121147807 | 10 VIAL, MULTI-DOSE in 1 CARTON (70121-1478-7) / 10 mL in 1 VIAL, MULTI-DOSE (70121-1478-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/856c3775-8925-4bd5-a93d-604829e73440
Use it
Look up 70121-1478 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70121-1478 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70121-1478. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.